INVESTIGATION OF ANTI-OBESITY ACTIVITY OF ETHANOLIC EXTRACT OF FOENICULUM VULGARE SEEDS, IN VIVO AND IN SILICO MODELS
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2019, Vol 8, Issue 11
Abstract
Background: Obesity is a chronic disease that triggers metabolic disorders due to excessive internal fat accumulation. Foeniculum vulgare (FV) is a very popular medicinal plant used to control obesity in the traditional medicine without any scientific evidence. Objectives: To evaluate the anti-obesity and anti-hyperlipidimic activity of ethanolic extract of Foeniculum vulgare seeds in vivo and identify the possible mechanism of action using molecular docking that is performed on plant constituent to target leptin receptor. Material and Methods: 16 albino rats were divided into four groups; group 1: none obese rats received (0.2 ml) normal saline daily, group 2: obesity control treated with modified High-fat hyper caloric diet, group 3: received plant extract (200 mg/kg) daily (I.P), and group 4: received Orlistat (2mg/kg) orally. Rats’ body weight and Lipid profile were assayed. For Molecular docking, ligands were obtained from previous studies, screening was performed using structure-based drug design against phytochemical constituent of Foeniculum vulgare, molecular modelling was done using Auto Dock Vina; only best conformers ligands with highest and best score was selected. Results: Reduction in rat’s body weights produced by Foeniculum vulgare ethanolic seed extract was12%, while Orlistat produced 6.4%. Triglycerides level wasn’t affected by treatment with plant extract and Orlistat. Molecular docking shows that Stigmast-5-en-3-ol have stronger binding at the leptin receptor’s binding site (-6.1 kcal/mol) when analyzed using AutoDockVina. Conclusion: Finally, this study concluded that Foeniculum vulgare ethanolic seeds extract demonstrate promising action as anti-obesity remedy since it shows a significant reduction in rat body weight and correct lipid profile, which provide scientific rationale for its folkloric use. Molecular docking suggests that the Stigmast-5-en-3-ol is a good candidate as leading compound for management of obesity disorders.
Authors and Affiliations
Dina A. Ghinmy
Keywords
Related Articles
- EP ID EP669815
- DOI -
- Views 116
- Downloads 0
FLOATING MICROSPHERES: A REVIEW
The real challenge in the development of an oral drug delivery system is not only to sustain the drug release but also to extend the presence of the dosage form within the gastrointestinal tract until all the drug is com...
A REVIEW ON MANAGEMENT OF OBESITY: PHARMACOLOGICAL VERSUS NON-PHARMACOLOGICAL APPROACH
When usual practice fails, people search for the new strategic management of obesity. Still the obesity is rarely cured, available treatment is only effective if they are continued in use. On stopping drug use, again the...
SHATAVARI (ASPARAGUS RACEMOSUS) A AYURVEDIC DRUG REVIEW
Ayurveda is an ancient and the oldest medical system in the world. Dating back almost 5000 years, it is also considered to be an ancient science of healing that enhances longevity. Herbal medicines are considered to be s...
ANTIBIOTIC DISPENSING WITHOUT PRESCRIPTION IN COMMUNITY PHARMACIES, DHAMAR PROVINCE, YEMEN
Background: The dispensing of antibiotics without medical prescription has been observed in many countries, particularly, in developing countries, including Yemen, where the legislations and regulations are weak. Objecti...
THE PREVALENCE OF SICKLE CELL ANEMIA AMONG PATIENTS ATTENDED PRIMARY HEALTH CARE CENTERS IN JAZAN REGION, SAUDI ARABIA
This was an observational, descriptive, cross sectional, primary health care facility based study in Jazan province in Kingdom Saudi Arabia. The total study population of 296 sickle cell anemia patients, homozygous for H...